Stockscreener 앱 받기
21.82
0.46%
-0.10
시간 외 거래:
21.86
0.04
+0.18%
Teva Pharmaceutical Industries Ltd Adr 주식(TEVA)의 최신 뉴스
Pain Management Therapeutics Market Is Expected To Reach Revenue Of USD 120.7 Bn By 2033, At 3.9% CAGR: Dimension Market Research. - GlobeNewswire Inc.
Citigroup Inc (NYSE: C) Up 37.25% This Year: What Is Going To Happen Next - Stocks Register
Where Do Analysts Think The Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) Is Going - Stocks Register
Fortuna Mining Corp Still Hasn’t Convinced Analysts? - Stocks Register
Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) 0.56% Incline Turns Investors Away - Stocks Register
Is Now The Time To Buy Abbvie Inc (NYSE: ABBV) Stock? - Stocks Register
PayPal Holdings Inc (NASDAQ: PYPL) Could Pass $95 In One Year Stock Forecast - Stocks Register
How Do Things Look For Boeing Co (NYSE: BA) In The Short-Term? - Stocks Register
What Did We Note About Insider Trading At Energy Transfer LP (NYSE: ET)? - Stocks Register
SelectQuote Inc Still Hasn’t Convinced Analysts? - Stocks Register
Barclays plc ADR (NYSE: BCS) Stock Sentiment: What’s Wall Street Saying? - Stocks Register
What Did We Note About Insider Trading At Altice USA Inc (NYSE: ATUS)? - Stocks Register
Walmart Inc (NYSE: WMT) -2.05% Decline Turns Investors Away - Stocks Register
What Did We Note About Insider Trading At Microsoft Corporation (NASDAQ: MSFT)? - Stocks Register
Where Do Analysts Think The Itau Unibanco Holding S.A. ADR (NYSE: ITUB) Is Going - Stocks Register
Hewlett Packard Enterprise Co (NYSE: HPE) Up 28.35% This Year: What Is Going To Happen Next - Stocks Register
Teva Pharmaceutical ADR Clears Technical Benchmark, Hitting 90-Plus RS Rating - Investor's Business Daily
Sandoz Group AG Sponsored ADR (SDZNY) Upgraded to Strong Buy: Here's What You Should Know - Yahoo Finance
Wall Street Analysts Think Molecular Partners AG Sponsored ADR (MOLN) Could Surge 80.72%: Read This Before Placing a Bet - Yahoo Finance
Is Kingsoft Cloud (KC) Outperforming Other Computer and Technology Stocks This Year? - Yahoo Finance
Opera Gains 27% in 3 Months: Should You Buy, Sell or Hold the Stock? - Yahoo Finance
Upcoming Nasdaq-100 changes could boost the stocks of these 11 companies - Yahoo Finance
Teva Pharmaceutical ADR Clears Technical Benchmark, Hitting 80-Plus RS Rating - Investor's Business Daily
Hello Group Inc. Sponsored ADR (MOMO) Surpasses Q3 Earnings and Revenue Estimates - Yahoo Finance
Foot Locker Inc (FL) Strikes $22.38: The Risk Seems Worthwhile At This Price - Stocks Register
Teva Pharmaceutical ADR Gets Relative Strength Rating Upgrade - Investor's Business Daily
Saudi Arabia Head And Neck Cancer Therapeutics Market Size & Outlook, 2030 - Grand View Research
Why Sony Group Corporation (SONY) Is One of the Best ADR Stocks to Invest in? - Yahoo Finance
Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year? - Yahoo Finance
New Strong Buy Stocks for November 26th - Yahoo Finance
Why MINISO Group Holding Limited Unsponsored ADR (MNSO) Outpaced the Stock Market Today - Yahoo Finance
Petrobras to Distribute R$ 20 Billion in Dividends - Yahoo Finance
10 Stocks With the Largest Fair Value Estimate Increases After Q3 Earnings - Morningstar
Is Atour Lifestyle Holdings Limited Sponsored ADR (ATAT) Outperforming Other Consumer Discretionary Stocks This Year? - Yahoo Finance
Full Truck Alliance Co. Ltd. Sponsored ADR (YMM) Q3 Earnings and Revenues Beat Estimates - Yahoo Finance
UK Head And Neck Cancer Therapeutics Market Size & Outlook, 2030 - Grand View Research
XPeng Inc. Sponsored ADR (XPEV) Increases Despite Market Slip: Here's What You Need to Know - Yahoo Finance
Sea Limited Q3 Earnings Miss Estimates, Shares Rise on Revenue Growth - Yahoo Finance
Such Is The Power Of CNH Industrial NV (NYSE: CNH) - Stocks Register
Hannover Rueck SE Reports Strong 2024 Earnings Growth - Yahoo Finance
Weekly Upgrades and Downgrades - InvestorPlace
Teva Pharmaceutical Industries ADR (TEVA-N) QuotePress Release - The Globe and Mail
XPeng Inc. Sponsored ADR (XPEV) Stock Moves -1.06%: What You Should Know - Yahoo Finance
Where Do Analysts See Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) Heading? - Stocks Register
Biliary Tract Cancer Market Research Report 2024-2030 with Analyst Recommendations - GlobeNewswire Inc.
Sea Limited Sponsored ADR (SE) Falls More Steeply Than Broader Market: What Investors Need to Know - Yahoo Finance
Li Auto Inc. Sponsored ADR (LI) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance
South Africa Central Nervous System Therapeutic Market Size & Outlook, 2028 - Grand View Research
Is Alstom (ALSMY) Outperforming Other Transportation Stocks This Year? - Yahoo Finance
Spain Head And Neck Cancer Therapeutics Market Size & Outlook, 2030 - Grand View Research
Italy Central Nervous System Therapeutic Market Size & Outlook, 2028 - Grand View Research
Germany Central Nervous System Therapeutic Market Size & Outlook, 2028 - Grand View Research
Is EXL Service (EXLS) Stock Outpacing Its Business Services Peers This Year? - Yahoo Finance
Is DMARKET Electronic Services & Trading (HEPS) Outperforming Other Retail-Wholesale Stocks This Year? - Yahoo Finance
Is AllianceBernstein (AB) Stock Outpacing Its Finance Peers This Year? - Yahoo Finance
Teva- Pharmaceutical Industries Ltd. ADR [TEVA] Is Currently 5.28 below its 200 Period Moving Avg: What Does This Mean? – The DBT News - The DBT News
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Stock: The Story of a 52-Week Stock Range - The InvestChronicle
Ophthalmic Disease Therapeutics Market Analysis by Age-related Macular Degeneration, Diabetic Macular Edema, & Other Retinal Disorders - GlobeNewswire Inc.
Is American Outdoor Brands (AOUT) Outperforming Other Consumer Discretionary Stocks This Year? - Yahoo Finance
1.83%
자본화:
|
볼륨(24시간):